Monitoring coping style moderates emotional reactions to genetic testing for hereditary nonpolyposis colorectal cancer: A longitudinal study

Psycho-Oncology

Volumn 17, Issue 8, 2008, Pages 746-755

  Shiloh, S ^a   Koehly, L ^b   Jenkins, J ^b   Martin, J ^c   Hadley, D ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c Department of Pharmacology and Toxicology ^*  (United States)

Author keywords

Cancer; Genetic testing; HNPCC; Monitoring coping style; Oncology

Indexed keywords

ADULT; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COLORECTAL CANCER; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DISTRESS SYNDROME; EMOTIONALITY; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; IMPACT OF EVENTS SCALE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILLER BEHAVIORAL STYLE SCALE; MUTATIONAL ANALYSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOTHERAPY;

ADAPTATION, PSYCHOLOGICAL; ADULT; AFFECT; ATTITUDE TO HEALTH; COLORECTAL NEOPLASMS; DEPRESSIVE DISORDER, MAJOR; EXPRESSED EMOTION; FEMALE; GENETIC COUNSELING; GENETIC TECHNIQUES; HUMANS; MALE; POINT MUTATION; QUESTIONNAIRES;

EID: 51649120912     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1338     Document Type: Article

References (78)

1. Peel DJ, Ziogas A, Fox EA et al. Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. J Natl Cancer Inst 2000;92:1517-1522.
2. Lindor NM, Petersen GM, Hadley DW et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome - a systematic review. J Am Med Assoc 2006;296:1507-1517.
3. Lynch HT, Lemon SJ, Karr B et al. Etiology, natural history, management, and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications. Cancer Epidemiol Biomarkers Prev 1997;6:987-991.
4. Moslein G, Krause-Paulus R, Hegger R et al. Clinical aspects of hereditary nonpolyposis colorectal cancer. Ann N Y Acad Sci 2000;910:75-84.
5. Jenkins MA, Baglietto L, Dowty JG et al. Cancer risks for mismatch repair gene mutations carriers: a population-based early onset case-family study. Clin Gastroenterol Hepato 2006; 4(4):489-498.
6. Offit K. Clinical Cancer Genetics. Risk Counseling and Management. Wiley: New York, 1997.
7. Jarvinen HJ, Aarnio M, Mustonen H et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. 2000;118(5):829-834.
8. Hadley DW, Jenkins J, Dimond E et al. Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med 2003;163:573-582.
9. Hadley DW, Jenkins JF, Dimond E et al. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2004;22:39-44.
10. Lerman C, Croyle R. Psychological issues in genetic testing for breast-cancer susceptibility. Arch Intern Med 1994; 154:609-616.
11. Rolland JS, Williams JK. Toward a biopsychosocial model for 21(st)-century genetics. Fam Process 2005;44:3-24.
12. Broadstock M, Michie S, Marteau T. Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 2000;8:731-738.
13. Lerman C, Croyle RT, Tercyak KP et al. Genetic testing: psychological aspects and implications. J Consult Clin Psycho 2002;70:784-797.
14. van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ et al. Prognostic factors for hereditary cancer distress six months after BRCA1/ 2 or HNPCC genetic susceptibility testing. Eur J Cancer 2007; 43:71-77.
15. Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-Oncology 2005;14:1060-1074.
16. Arver B, Haegermark A, Platten U et al. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up. Fam Cancer 2004; 3:109-l16.
17. Wagner A, van Kessel I, Kriege MG et al. Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Fam Cancer 2005; 4:295-300.
18. Claes E, Denayer L, Evers-Kiebooms G et al. Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test. Genet Test 2005; 9:54-65.
19. Meiser B, Collins V, Warren R et al. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet 2004;66:502-511.
20. Gritz ER, Peterson SK, Vernon SW et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005;23:1902-1910.
21. Rimes KA, Salkovskis PA, Jones L et al. Applying a cognitive-behavioral model of health anxiety in a cancer genetics service. Health Psychol 2006;25:171-180.
22. Murakami Y, Okamura H, Sugano K et al. Psychologic distress after disclosure of genetic test results regarding hereditary nonpolyposis colorectal carcinoma - a preliminary report. Cancer 2004; 101:395-403.
23. van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ et al. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. Patient Educ Couns 2007;65:58-68.
24. Croyle RT, Smith KR, Botkin JR et al. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 1997;16:63-72.
25. Bonadona V, Saltel P, Desseigne FO et al. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidemiol Biomarkers Prev 2002;11:97-l04.
26. Dorval M, Patenaude AF, Schneider KA et al. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. J Clin Oncol 2000;18:2135-2142.
27. Farkas Patenaude A. Genetic Testing for Cancer: Psychologicat Approaches for Helping Patients and Families. American Psychological Association: Washington, DC, 2005;134.
28. Tercyak KP, Lerman C, Peshkin BN et al. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychol 2001;20:217-222.
29. Aktan-Collan K, Haukkala A, Mecklin JP et al. Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer 2001;93:608-611.
30. Claes E, Denayer L, Evers-Kiebooms G et al. Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Educ Couns 2004;55:265-274.
31. Geirdal AO, Reichelt JG, Dahl AA et al. Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations. Fam Cancer 2005; 4:121-126.
32. van Dijk S, Timmermans DRM, Meijers-Heijboer H et al. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. J Clin Oncol 2006;24: 3672-3677.
33. Miller SM, Roussi P, Caputo GC, Kruus L. Patterns of childrens' coping with an aversive dental treatment. Health Psychol 1995; 14:236-246.
34. Lerman C, Schwartz MD, Miller SM et al. A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style. Health Psychol 1996; 15:75-83.
35. Miller SM. Monitoring and Blunting - validation of a questionnaire to assess styles of information seeking under threat. J Pers Soc Psychol 1987;52:345-353.
36. Miller SM. Monitoring versus blunting styles of coping with cancer influence the information patients want and need about their disease - implications for cancer screening and management. Cancer 1995; 76:167-177.
37. Miller SM, Shoda Y, Hurley K. Applying cognitive social theory to health-protective behavior: breast self-examination in cancer screening. Psychol Bull 1996; 119:70-94.
38. Muris P, van Zuuren FJ, Kindt M. Monitoring coping style, fear of AIDS, and attitudes towards AIDS-prevention. Soc Behav Pers 1994; 22:137-143.
39. Lerman C. Psychological aspects of genetic testing: introduction to the special issue. Health Psychol 1997; 16:3-7.
40. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994; 12:843-850.
41. Lerman C, Seay J, Balshem A, Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995;57:385-392.
42. Shiloh S, Ben-Sinai R, Keinan G. Effects of controllability, predictability, and information-seeking style on interest in predictive genetic testing. Pers Soc Psychol Bull 1999;25:1187-1195.
43. Schwartz MD, Lerman C, Miller SM et al. Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian-cancer. Health Psychol 1995;14:232-235.
44. Miller SM, Roussi P, Altman D et al. Effects of coping style on psychological reactions of low-income, minority women to colposcopy. J Reprod Med 1994;39:711-718.
45. Miller SM, Rodoletz M, Schoreder CM et al. Applications of the monitoring process model to coping with severe long-term medical threats. Health Psychol 1996;15:216-225.
46. Wardle J. Women at risk of ovarian cancer. J Natl Cancer Inst 1995;17:81-85.
47. Shoda Y, Mischel W, Miller SM et al. Psychological interventions and genetic testing: facilitating informed decisions about BRCA1/2 cancer susceptibility. J Clin Psychol Med Settings 1998; 5:3-17.
48. Baum A, Friedman AL, Zakowski SG. Stress and genetic testing for disease risk. Health Psychol 1997; 16:8-19.
49. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979;41:209-218.
50. Halbert CH, Lynch H, Lynch J et al. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 2004; 164:1881-1887.
51. Radloff LS. The CES-D scale: a self-report depression scale for research in he general population. Appl Psychol Meas 1977;1.
52. Bijttebier P, Vertommen H, Vander Steene G. Assessment of cognitive coping styles: a closer look at situation-response inventories. Clin Psychol Rev 2001;21:85-104.
53. Rees CE, Bath PA. The psychometric properties of the Miller Behavioural Style Scale with adult daughters of women with early breast cancer: a literature review and empirical study. J Adv Nurs 2000; 32:366-374.
54. Keller M, Jost R, Haunstetter CM et al. Comprehensive genetic counseling for families at risk for HNPCC: impact on distress and perceptions. Genet Test 2002;6:291-302.
55. DudokdeWit AC, Tibben A, Duivenvoorden HJ et al. Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? J Med Genet 1998;35:745-754.
56. Shiloh S, Berkenstadt M, Meiran N et al. Mediating effects of perceived personal control in coping with a health threat: the case of genetic counseling. J Appl Soc Psychol 1997;27:1146-1174.
57. Proctor R, Martin C, Hewison J. When a little knowledge is a dangerous thing...: a study of carers' knowledge about dementia, preferred coping style and psychological distress. Int J Geriatr Psychiatry 2002; 17:1133-1139.
58. Andrykowski MA, Boerner LM, Salsman JM et al. Psychological response to test results in an ovarian cancer screening program: a prospective, longitudinal study. Health Psychol 2004; 23:622-630.
59. Sparks GG, Spirek MM. Individual-differences in coping with stressful mass-media - an activation - arousal view. Hum Commun Res 1988; 15:195-216.
60. Van Zuuren FJ, Muris P. Coping under experimental threat - observable and cognitive correlates of dispositional monitoring and blunting. Eur J Pers 1993;7: 245-253.
61. Cheng C, Cheung MWL. Cognitive processes underlying coping flexibility: differentiation and integration. J Pers 2005;73:859-886.
62. Voss U, Muller H, Schermelleh-Engel K. Towards the assessment of adaptive vs. rigid coping styles: validation of the Frankfurt Monitoring Blunting Scales by means of confirmatory factor analysis. Pers Individ Differ 2006;41:295-306.
63. Steptoe A, O'Sullivan J. Monitoring and blunting coping styles in women prior to surgery. Br J Clin Psychol 1986;24:143-144.
64. Bowen DJ, Farkas Patenaude A, Vernon SW. Psychosocial issues in cancer genetics: from the laboratory to the public. Cancer Epidemiol Biomarkers Prev 1999;8:326-328.
65. Davis TMA, Maguire TO, Haraphongse M et al. Preparing adult patients for cardiac-catheterization - informational treatment and coping style interactions. Heart Lung 1994;23:130-139.
66. Gattuso SM, Fitzgerald TE, Litt MD. Coping with gastrointestinal endoscopy - self-efficacy enhancement and coping style. J Consult Clin Psychol 1992;60: 133-139.
67. Jacob TC, Penn NE, Kulik JA et al. Effects of cognitive-style and maintenance strategies on breast self-examination (BSE) practice by African-American women. J Behav Med 1992;15:589-609.
68. Lerman C, Rimer B, Trock B et al. Factors associated with repeat adherence to breast-cancer screening. Prev Med 1990; 19:279-290.
69. Leventhal EA, Leventhal H, Shacham S et al. Active coping reduces reports of pain from childbirth. J Consult Clin Psychol 1989; 57:365-371.
70. Ludwick-Rosenthal R, Neufeld WJ. Preparation for undergoing an invasive medical procedure - interacting effects of information and coping style. J Consult Clin Psychol 1993;61:156-164.
71. Miller SM, Mangan CE. Interacting effects of information and coping style in adapting to gynecologic stress - should the doctor tell all. J Pers Soc Psychol 1983;45:223-236.
72. Miller SM, Buzaglo JS, Simms SL et al. Monitoring styles in women at risk for cervical cancer: implications for the framing of health-relevant messages. Ann Behav Med 1999;21:27-34.
73. Sparks GG. Understanding emotional-reactions to a suspenseful movie - the interaction between forewarning and preferred coping style. Commun Monogr 1989;56:325-340.
74. Watkins LO, Weaver L, Odegaard V. Preparation for cardiac-catheterization-tailoring the content of instruction to coping style. Heart Lung 1986;15: 382-389.
75. van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ et al. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. Clin Genet 2007;71:35-42.
76. Williams-Piehota P, Pizarro J, Schneider TR et al. Matching health messages to monitor-blunter coping styles to motivate screening mammography. Health Psychol 2005;24:58-67.
77. Andrykowski MA, Carpenter JS, Studts JL et al. Psychological impact of benign breast biopsy: a longitudinal, comparative study. Health Psychol 2002;21: 485-494.
78. Miller SM, Roussi P, Daly MB et al. Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors. Health Educ Behav 2005; 32:654-667.